These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
317 related items for PubMed ID: 19105967
1. Multifunctional effect of epigallocatechin-3-gallate (EGCG) in downregulation of gelatinase-A (MMP-2) in human breast cancer cell line MCF-7. Sen T, Moulik S, Dutta A, Choudhury PR, Banerji A, Das S, Roy M, Chatterjee A. Life Sci; 2009 Feb 13; 84(7-8):194-204. PubMed ID: 19105967 [Abstract] [Full Text] [Related]
2. (-)-Epigallocatechin-3-gallate down-regulates EGFR, MMP-2, MMP-9 and EMMPRIN and inhibits the invasion of MCF-7 tamoxifen-resistant cells. Farabegoli F, Papi A, Orlandi M. Biosci Rep; 2011 Apr 13; 31(2):99-108. PubMed ID: 20446926 [Abstract] [Full Text] [Related]
3. Epigallocatechin-3-gallate (EGCG) downregulates gelatinase-B (MMP-9) by involvement of FAK/ERK/NFkappaB and AP-1 in the human breast cancer cell line MDA-MB-231. Sen T, Dutta A, Chatterjee A. Anticancer Drugs; 2010 Jul 13; 21(6):632-44. PubMed ID: 20527725 [Abstract] [Full Text] [Related]
4. Association of suppression of extracellular signal-regulated kinase phosphorylation by epigallocatechin gallate with the reduction of matrix metalloproteinase activities in human fibrosarcoma HT1080 cells. Maeda-Yamamoto M, Suzuki N, Sawai Y, Miyase T, Sano M, Hashimoto-Ohta A, Isemura M. J Agric Food Chem; 2003 Mar 26; 51(7):1858-63. PubMed ID: 12643642 [Abstract] [Full Text] [Related]
5. (-)-Epigallocatechin-3-gallate promotes pro-matrix metalloproteinase-7 production via activation of the JNK1/2 pathway in HT-29 human colorectal cancer cells. Kim M, Murakami A, Kawabata K, Ohigashi H. Carcinogenesis; 2005 Sep 26; 26(9):1553-62. PubMed ID: 15860507 [Abstract] [Full Text] [Related]
6. Green tea polyphenol epigallocatechin-3-gallate suppresses rat hepatic stellate cell invasion by inhibition of MMP-2 expression and its activation. Zhen MC, Huang XH, Wang Q, Sun K, Liu YJ, Li W, Zhang LJ, Cao LQ, Chen XL. Acta Pharmacol Sin; 2006 Dec 26; 27(12):1600-7. PubMed ID: 17112415 [Abstract] [Full Text] [Related]
7. Tea polyphenol (-)-epigallocatechin 3-gallate suppresses heregulin-beta1-induced fatty acid synthase expression in human breast cancer cells by inhibiting phosphatidylinositol 3-kinase/Akt and mitogen-activated protein kinase cascade signaling. Pan MH, Lin CC, Lin JK, Chen WJ. J Agric Food Chem; 2007 Jun 27; 55(13):5030-7. PubMed ID: 17539658 [Abstract] [Full Text] [Related]
8. Treatment of epigallocatechin-3-gallate inhibits matrix metalloproteinases-2 and -9 via inhibition of activation of mitogen-activated protein kinases, c-jun and NF-kappaB in human prostate carcinoma DU-145 cells. Vayalil PK, Katiyar SK. Prostate; 2004 Apr 01; 59(1):33-42. PubMed ID: 14991864 [Abstract] [Full Text] [Related]
10. Epigallocatechin-3-gallate (EGCG) downregulates EGF-induced MMP-9 in breast cancer cells: involvement of integrin receptor α5β1 in the process. Sen T, Chatterjee A. Eur J Nutr; 2011 Sep 01; 50(6):465-78. PubMed ID: 21170718 [Abstract] [Full Text] [Related]
11. EGCG inhibits the invasion of highly invasive CL1-5 lung cancer cells through suppressing MMP-2 expression via JNK signaling and induces G2/M arrest. Deng YT, Lin JK. J Agric Food Chem; 2011 Dec 28; 59(24):13318-27. PubMed ID: 22082235 [Abstract] [Full Text] [Related]
12. Green tea (-)-epigallocatechin-3-gallate down-regulates VASP expression and inhibits breast cancer cell migration and invasion by attenuating Rac1 activity. Zhang Y, Han G, Fan B, Zhou Y, Zhou X, Wei L, Zhang J. Eur J Pharmacol; 2009 Mar 15; 606(1-3):172-9. PubMed ID: 19171136 [Abstract] [Full Text] [Related]
13. (-)-Epigallocatechin 3-gallate inhibits invasion by inducing the expression of Raf kinase inhibitor protein in AsPC‑1 human pancreatic adenocarcinoma cells through the modulation of histone deacetylase activity. Kim SO, Kim MR. Int J Oncol; 2013 Jan 15; 42(1):349-58. PubMed ID: 23135610 [Abstract] [Full Text] [Related]
14. Green tea polyphenol epigallocatechin-3-gallate (EGCG) differentially inhibits interleukin-1 beta-induced expression of matrix metalloproteinase-1 and -13 in human chondrocytes. Ahmed S, Wang N, Lalonde M, Goldberg VM, Haqqi TM. J Pharmacol Exp Ther; 2004 Feb 15; 308(2):767-73. PubMed ID: 14600251 [Abstract] [Full Text] [Related]
15. Kalopanaxsaponin A inhibits PMA-induced invasion by reducing matrix metalloproteinase-9 via PI3K/Akt- and PKCdelta-mediated signaling in MCF-7 human breast cancer cells. Park SK, Hwang YS, Park KK, Park HJ, Seo JY, Chung WY. Carcinogenesis; 2009 Jul 15; 30(7):1225-33. PubMed ID: 19420016 [Abstract] [Full Text] [Related]
16. EGCG down-regulates telomerase in human breast carcinoma MCF-7 cells, leading to suppression of cell viability and induction of apoptosis. Mittal A, Pate MS, Wylie RC, Tollefsbol TO, Katiyar SK. Int J Oncol; 2004 Mar 15; 24(3):703-10. PubMed ID: 14767556 [Abstract] [Full Text] [Related]
17. Fibronectin induces matrix metalloproteinase-9 (MMP-9) in human laryngeal carcinoma cells by involving multiple signaling pathways. Sen T, Dutta A, Maity G, Chatterjee A. Biochimie; 2010 Oct 15; 92(10):1422-34. PubMed ID: 20638438 [Abstract] [Full Text] [Related]
18. Epigallocatechin-3-gallate inhibits the invasion of human oral cancer cells and decreases the productions of matrix metalloproteinases and urokinase-plasminogen activator. Ho YC, Yang SF, Peng CY, Chou MY, Chang YC. J Oral Pathol Med; 2007 Nov 15; 36(10):588-93. PubMed ID: 17944751 [Abstract] [Full Text] [Related]
19. Green tea polyphenol EGCG suppresses cigarette smoke condensate-induced NF-kappaB activation in normal human bronchial epithelial cells. Syed DN, Afaq F, Kweon MH, Hadi N, Bhatia N, Spiegelman VS, Mukhtar H. Oncogene; 2007 Feb 01; 26(5):673-82. PubMed ID: 16862172 [Abstract] [Full Text] [Related]
20. EGCG blocks tumor promoter-induced MMP-9 expression via suppression of MAPK and AP-1 activation in human gastric AGS cells. Kim HS, Kim MH, Jeong M, Hwang YS, Lim SH, Shin BA, Ahn BW, Jung YD. Anticancer Res; 2004 Feb 01; 24(2B):747-53. PubMed ID: 15161022 [Abstract] [Full Text] [Related] Page: [Next] [New Search]